Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 5.7 million
熱評(píng):
方生物(+59.95萬股/新進(jìn))同時(shí)該私募產(chǎn)品還現(xiàn)身風(fēng)電運(yùn)營商標(biāo)的龍?jiān)措娏Α㈦娐钒迳a(chǎn)商崇達(dá)技術(shù)、腫瘤治療設(shè)備盈康生命、和煤化工生產(chǎn)商金能科技四家上市公司的前十大流通股東之列。董承非管理的另一只??び?
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net loss of 61 million yuan
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net loss of 138.7 million
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 249.2 million
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 260 million
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 174.3 million
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 124.1 million
圖片
視頻
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 5.7 million
熱評(píng):
方生物(+59.95萬股/新進(jìn))同時(shí)該私募產(chǎn)品還現(xiàn)身風(fēng)電運(yùn)營商標(biāo)的龍?jiān)措娏Α㈦娐钒迳a(chǎn)商崇達(dá)技術(shù)、腫瘤治療設(shè)備盈康生命、和煤化工生產(chǎn)商金能科技四家上市公司的前十大流通股東之列。董承非管理的另一只??び?
熱評(píng):
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net loss of 61 million yuan
熱評(píng):
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net loss of 138.7 million
熱評(píng):
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 249.2 million
熱評(píng):
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 260 million
熱評(píng):
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 174.3 million
熱評(píng):
Jinneng Science&Technology Co.,Ltd. (金能科技股份有限公司) (603113.SH) reported a net profit of 124.1 million
熱評(píng):